Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.580
-0.060 (-2.27%)
At close: Aug 20, 2026, 4:00 PM EDT
2.560
-0.020 (-0.78%)
After-hours: Aug 20, 2026, 7:06 PM EDT
Veru Inc. Market Cap
Veru Inc. has a market cap or net worth of $43.99 million as of August 20, 2026. Its market cap has decreased by -7.39% in one year.
Market Cap
43.99M
Enterprise Value
20.94M
1-Year Change
-7.39%
Ranking
Category
Stock Price
$2.58
ChartMarket Cap Chart
Since December 1, 1998, Veru Inc.'s market cap has increased from $15.60M to $43.99M, an increase of 181.99%. That is a compound annual growth rate of 3.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 43.99M | 28.25% |
| Dec 31, 2025 | 34.30M | -63.97% |
| Dec 31, 2024 | 95.20M | 41.25% |
| Dec 29, 2023 | 67.40M | -84.17% |
| Dec 30, 2022 | 425.70M | -9.69% |
| Dec 31, 2021 | 471.40M | -22.24% |
| Dec 31, 2020 | 606.20M | 178.20% |
| Dec 31, 2019 | 217.90M | 148.46% |
| Dec 31, 2018 | 87.70M | 44.48% |
| Dec 29, 2017 | 60.70M | 112.98% |
| Dec 30, 2016 | 28.50M | -32.30% |
| Dec 31, 2015 | 42.10M | -62.74% |
| Dec 31, 2014 | 113.00M | -53.73% |
| Dec 31, 2013 | 244.20M | 18.60% |
| Dec 31, 2012 | 205.90M | 63.80% |
| Dec 30, 2011 | 125.70M | -19.63% |
| Dec 31, 2010 | 156.40M | 24.42% |
| Dec 31, 2009 | 125.70M | 30.39% |
| Dec 31, 2008 | 96.40M | 38.31% |
| Dec 31, 2007 | 69.70M | 85.87% |
| Dec 29, 2006 | 37.50M | -7.64% |
| Dec 30, 2005 | 40.60M | -11.74% |
| Dec 31, 2004 | 46.00M | -14.34% |
| Dec 31, 2003 | 53.70M | 88.42% |
| Dec 31, 2002 | 28.50M | 139.50% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alps Group | 49.19M |
| Metagenomi Therapeutics | 45.71M |
| Context Therapeutics | 45.62M |
| Veraxa Biotech AG | 45.14M |
| Grace Therapeutics | 44.81M |
| Karyopharm Therapeutics | 43.78M |
| Seres Therapeutics | 43.15M |
| Aligos Therapeutics | 42.21M |